Complix's Grant - II Round

Complix raised a round of funding on October 30, 2012. Investors include IWT.

Complix is a biopharmaceutical company developing a pipeline of transformative protein therapeutics, called Alphabodies, that mainly focus on oncology and autoimmune diseases. Alphabodies are a class …

Articles about Complix's Grant - II Round: